Market Tracker

04/28 5:16pm ET

Apricus Biosciences Inc (NASDAQ:APRI)

1.13
Delayed Data
As of Apr 28
 +0.02 / +1.80%
Today’s Change
1.07
Today|||52-Week Range
5.95
-13.08%
Year-to-Date
No recent news for Apricus Biosciences Inc.

Today’s Trading

Previous close1.11
Today’s open1.10
Day’s range1.07 - 1.13
Volume561,708
Average volume (3 months)1,042,804
Market cap$14.2M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+70.20%
Earnings growth (this year)+111.11%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.09%
P/E ratioNM
Price/Sales1.47
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MBVXMabVax Therapeutics ...+0.06+2.71%
TKAITokai Pharmaceutical...-0.00-0.67%
SBOTStellar Biotechnolog...+0.01+0.75%
CBIOCatalyst Biosciences...+0.30+5.99%
Data as of 3:59pm ET, 04/28/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)$1.25
Annual revenue (last year)$5.8M
Annual profit (last year)-$7.4M
Net profit margin-128.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer, CAO, Secretary &
Director
Richard W. Pascoe
Chief Business Officer &
Senior Vice President
Neil C. Morton
Corporate headquarters
San Diego, California

Forecasts